Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 95269442 | 9526944 | 2 | F | 20110805 | 20160715 | 20130916 | 20160723 | EXP | CA-009507513-1309CAN006144 | MERCK | 6.00 | YR | F | Y | 30.84000 | KG | 20160723 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 95269442 | 9526944 | 1 | PS | SINGULAIR | MONTELUKAST SODIUM | 1 | Oral | 5 MG, 1 DOSAGE FORM, HS | N | 20829 | 5 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 95269442 | 9526944 | 1 | Asthma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 95269442 | 9526944 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 95269442 | 9526944 | Abnormal dreams | |
| 95269442 | 9526944 | Aggression | |
| 95269442 | 9526944 | Agitation | |
| 95269442 | 9526944 | Anxiety | |
| 95269442 | 9526944 | Depression | |
| 95269442 | 9526944 | Hallucination | |
| 95269442 | 9526944 | Insomnia | |
| 95269442 | 9526944 | Intentional self-injury | |
| 95269442 | 9526944 | Mental disorder | |
| 95269442 | 9526944 | Mood altered | |
| 95269442 | 9526944 | Pain in extremity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |